COLUMBIA LABORATORIES R&D PIPELINE
|
Product/Candidate |
Potential Indication |
Dev. |
I |
II |
III |
|
PROCHIEVE 8% Vaginal Gel |
Reduce the risk of preterm birth in women with a short cervix |
Phase III study to be initiated Q4 2007 |
|||
|
PROCHIEVE 4% Vaginal Gel |
Endometrial hyperplasia in HRT patients |
Third-party study; CBRX providing product only |
|
||
|
Prevent and treat dysmenorrhea |
Phase II cross-over study underway |
|
|||
|
Vaginal testosterone |
Uterine fibroid reduction |
|
|
|
|
|
Desmopressin Buccal Tablet |
Nocturnal enuresis in children |
Partnership sought |
|
|
|
|
Vaginal carbamide peroxide |
|||||
|
Various projects using BDS for vaginal drug delivery |
|||||